$11.22
-0.25-2.18%
Last update: Nov 10, 4:00 PM
Enanta Pharmaceuticals Inc
ENTANASDAQ
The average analyst price target for Enanta Pharma is $19, 69.3% above the current price. Of 6 analysts, 6 rate it Buy. Targets range from $10 to $28. The latest change came on Nov 14, 2025, when JP Morgan initiated coverage of Enanta Pharma with an Overweight rating and a $17 price target.
Price Target Range — 12 Quarters
Analyst Consensus — 6 Analysts
Rating Trend — Last 9 Months
